124 related articles for article (PubMed ID: 24365398)
1. Interference of gadolinium-based contrast agents on colorimetric calcium assays.
Yan R; Tarr H; McNally M; Cartier LJ; Chen Y
Clin Biochem; 2014 May; 47(7-8):648-53. PubMed ID: 24365398
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of NM-BAPTA method for plasma total calcium measurement on Cobas 8000®.
Bourguignon C; Dupuy AM; Coste T; Michel F; Cristol JP
Clin Biochem; 2014 May; 47(7-8):636-9. PubMed ID: 24406301
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays.
Proctor KA; Rao LV; Roberts WL
Am J Clin Pathol; 2004 Feb; 121(2):282-92. PubMed ID: 14983944
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of two gadolinium-containing contrast-enhancing agents, gadobutrol and gadoxetate disodium, on colorimetric calcium determinations in serum and plasma.
Löwe A; Breuer J; Palkowitsch P
Invest Radiol; 2011 Jun; 46(6):366-9. PubMed ID: 21285889
[TBL] [Abstract][Full Text] [Related]
5. Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method.
Kang HP; Scott MG; Joe BN; Narra V; Heiken J; Parvin CA
Clin Chem; 2004 Apr; 50(4):741-6. PubMed ID: 14962999
[TBL] [Abstract][Full Text] [Related]
6. Measurement of serum calcium concentration after administration of four gadolinium-based contrast agents to human volunteers.
Brown JJ; Hynes MR; Wible JH
AJR Am J Roentgenol; 2007 Dec; 189(6):1539-44. PubMed ID: 18029898
[TBL] [Abstract][Full Text] [Related]
7. Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents.
Fretellier N; Poteau N; Factor C; Mayer JF; Medina C; Port M; Idée JM; Corot C
Invest Radiol; 2014 Dec; 49(12):766-72. PubMed ID: 24943092
[TBL] [Abstract][Full Text] [Related]
8. Interference of gadolinium-containing contrast-enhancing agents with colorimetric calcium laboratory testing.
Löwe A; Balzer T; Hirt U
Invest Radiol; 2005 Aug; 40(8):521-5. PubMed ID: 16024990
[TBL] [Abstract][Full Text] [Related]
9. Influence of magnetic resonance contrast media on the activity of histamine inactivating enzymes.
Kuefner MA; Feurle J; Uder M; Bautz W; Schwelberger HG
Acad Radiol; 2009 Mar; 16(3):358-62. PubMed ID: 19201365
[TBL] [Abstract][Full Text] [Related]
10. Measurement of serum calcium concentration after administration of gadoversetamide in dogs.
Wible JH; Hynes MR
Radiology; 2004 Oct; 233(1):158-64. PubMed ID: 15454620
[TBL] [Abstract][Full Text] [Related]
11. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.
Frenzel T; Lengsfeld P; Schirmer H; Hütter J; Weinmann HJ
Invest Radiol; 2008 Dec; 43(12):817-28. PubMed ID: 19002053
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of liver and pancreas on late hepatic arterial phase imaging: quantitative comparison among multiple gadolinium-based contrast agents at 1.5 Tesla MRI.
Kim MJ; Kim SH; Kim HJ; Kim BS; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Jul; 38(1):102-8. PubMed ID: 23677890
[TBL] [Abstract][Full Text] [Related]
13. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
Davenport MS; Caoili EM; Kaza RK; Hussain HK
Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of dynamic nuclear polarisation of [1-(13)C] pyruvate by addition of gadolinium-based contrast agents.
Friesen-Waldner L; Chen A; Mander W; Scholl TJ; McKenzie CA
J Magn Reson; 2012 Oct; 223():85-9. PubMed ID: 22975238
[TBL] [Abstract][Full Text] [Related]
15. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
16. Profound pseudohypocalcemia due to gadolinium (Magnevist) contrast in a hemodialysis patient.
Davenport A; Whiting S
Am J Kidney Dis; 2006 Feb; 47(2):350-2. PubMed ID: 16431265
[TBL] [Abstract][Full Text] [Related]
17. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
[TBL] [Abstract][Full Text] [Related]
18. Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium.
Normann PT; Frøysa A; Svaland M
Scand J Clin Lab Invest; 1995 Aug; 55(5):421-6. PubMed ID: 8545600
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
20. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
